Objectives: The main neuropathological hallmarks of Parkinson's disease (PD) are loss of nigro-striatal dopamine neurons and intraneuronal Lewy Bodies (LB), proteinaceous inclusions mainly composed by a-synuclein. Recently, we found that a-synuclein interacts and cooperates with a specific member of the synapsin phosphoprotein family: synapsin III, in the regulation of dopaminergic neuron function. The aim of this study was to investigate whether synapsin III alterations may be related to a-synuclein pathology in PD. We thus investigated the occurrence of alterations of synapsin III expression and distribution in “the brain of patients affected by PD and DLB (Human brain samples were kindly provided by the UK Parkinson's disease Brain Bank). Methods: We used molecular biology and immunohistochemical techniques as well as the “in situ” proximity ligation assay (PLA) to investigate the expression levels and the distribution of synapsin III in the PD brain. Results: By immunohistochemistry, we showed a marked accumulation of synapsin III in the caudate/putamen of patients affected by PD when compared to age matched controls. In addition, many LB-like structures in the substantia nigra of PD patients were found to be immunoreactive for synapsin III, that by confocal fluorescence microscopy resulted to be accumulated in the core of LB. By co-immunoprecipitation and “in situ” PLA we found that synapsin III directly interacted with a-synuclein and that these two proteins were co-redistributed in mice and human brains. Finally, western blot analysis showed significant alterations of synapsin III levels that correlated with alteration of a-synuclein in the caudate/putamen and substantia nigra of PD patients. Conclusions: Altogether, our data support a critical involvement of synapsin III in PD pathophysiology
Synapsin III alterations in Parkinson's disease
Bellucci, Arianna;Zaltieri, Michela;Longhena, Francesca;Faustini, Gaia;Grigoletto, Jessica;Favero, Gaia;Castrezzati, Stefania;Rezzani, Rita;Pizzi, Marina;Missale, Cristina;Spano, PierFranco
2016-01-01
Abstract
Objectives: The main neuropathological hallmarks of Parkinson's disease (PD) are loss of nigro-striatal dopamine neurons and intraneuronal Lewy Bodies (LB), proteinaceous inclusions mainly composed by a-synuclein. Recently, we found that a-synuclein interacts and cooperates with a specific member of the synapsin phosphoprotein family: synapsin III, in the regulation of dopaminergic neuron function. The aim of this study was to investigate whether synapsin III alterations may be related to a-synuclein pathology in PD. We thus investigated the occurrence of alterations of synapsin III expression and distribution in “the brain of patients affected by PD and DLB (Human brain samples were kindly provided by the UK Parkinson's disease Brain Bank). Methods: We used molecular biology and immunohistochemical techniques as well as the “in situ” proximity ligation assay (PLA) to investigate the expression levels and the distribution of synapsin III in the PD brain. Results: By immunohistochemistry, we showed a marked accumulation of synapsin III in the caudate/putamen of patients affected by PD when compared to age matched controls. In addition, many LB-like structures in the substantia nigra of PD patients were found to be immunoreactive for synapsin III, that by confocal fluorescence microscopy resulted to be accumulated in the core of LB. By co-immunoprecipitation and “in situ” PLA we found that synapsin III directly interacted with a-synuclein and that these two proteins were co-redistributed in mice and human brains. Finally, western blot analysis showed significant alterations of synapsin III levels that correlated with alteration of a-synuclein in the caudate/putamen and substantia nigra of PD patients. Conclusions: Altogether, our data support a critical involvement of synapsin III in PD pathophysiologyFile | Dimensione | Formato | |
---|---|---|---|
Bellucci et al., 2016.pdf
solo utenti autorizzati
Tipologia:
Abstract
Licenza:
Dominio pubblico
Dimensione
55.7 kB
Formato
Adobe PDF
|
55.7 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.